from some likes I have received in the last few weeks and the trading from 2.5c to 3.5c, we have some new eyes looking at ADO at the moment. regulars would have seen this from me before but as I said it's for the newbies. plenty of advice from other posters about why ado is not a worthwhile investment, read them if you want to listen to some major bedwetter opinions.
these are the short term opportunities Anteotech has developed over the last few years in their CET and lifescience divisions
not a bad pipeline of opportunities for a $70M market cap company. the main division I have focused on lately is the battery division. if you ask yourself why we haven't got a battery deal yet here is the progression of ADO' s CET over the last 16 months leaving us at the pointy end of tech evaluation and commercial deals.
post 70982233
main points about battery commercialisation coming from the CEO at the AGM
- from EV 1 'If we continue on the trajectory that we are, this (ADO tech) will go to the entire fleet of cars."
"...with the conversations we had in Europe, it's been reaffirmed to us that where we are at in the clean energy space is quite unique. So right now, these Giga Factories and EV companies are not aware of anything else they want to evaluate"
"and as recently as Friday, Friday evening, we were having a conversation with the EV company, and they've been asked to access the other opportunities in anode development, and his comment was it's a very short project for me because there is nothing that comes close to where you are at"
If EV1 used anteox, we can generate $300m extra profit for them by cost savings.
at this stage we have contract proposals with Trinseo, Wyon, a battery manufacturer and an ev company.
in regards to funding "AnteoTech has commenced the process to apply for three separate grants for government funding through a matched funding model, to advance the development of the Clean Energy Technologies.
These Australian grants, if successful will enable the accelerated development of the silicon anode project and also expansion into the newer target areas that may include green hydrogen. It is not anticipated that the Company will receive a response prior to late 2023 due to the processes for the applications."
some posts to look at into regarding the likelihood of non dilutionary funding
70515727
68205820
66982333
so funding for development of our production facility and our CET advancements coming from non dilutionary gov't grants are to be considered.
as well as the $260k order Anteotech just received from the biggest vaccine manufacturer in the world, Serum Institute of India and the $60K order from ev company 1 for anteoX and our anode technology for further testing. revenue as stated from management is starting.
some connections we have to these gov't agencies and the connection Katherine has to gov't
69562300
70107881
plenty more available. we are still a spec stock with all the spec risks but one or more of the above companies sign a deal and ADO will quickly remove the spec tag.
DYOR, IMO, GLTAH etc etc.....
2024 the year of ADO .............
- Forums
- ASX - By Stock
- ADO
- A few km into the marathon.
A few km into the marathon., page-149
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M |
Open | High | Low | Value | Volume |
2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 541015 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 4693635 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 537498 | 0.027 |
7 | 653551 | 0.026 |
13 | 1982099 | 0.025 |
7 | 2179250 | 0.024 |
4 | 1110217 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 4693635 | 4 |
0.030 | 359200 | 3 |
0.031 | 75000 | 1 |
0.032 | 191382 | 2 |
0.034 | 428717 | 4 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online